Form D · Other Health Care

Pulsenmore Ltd.

Omer, L3 · CIK 0002064764

Offering snapshot reported Jul 7, 2026 · SEC filing

Reported sold
$7.5M
Offering amount: $7.5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 26, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 7, 2026Initial$7,500,000No comparison1SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$525K
Finders' fees
$0
Form D file number
021-589745
An offering of 1,562,500 pre-funded warrants and 1,562,500 ordinary warrants, at a purchase price of $4.7999 per pre-funded warrant and accompanying ordinary warrant.
The Placement Agent also received $50,000 accountable out-of-pocket legal expenses.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
A.G.P. / Alliance Global Partners000008361

Source: Form D, filed Jul 7, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jonathan Adereth Director
Racheli Guz Lavi Director
Michael Hamelsdorf Executive
Eran Hirsh Executive
Hagai Itkin Director
Anat Loewenstein Director
Linda Messalem Director
Meir Shmouely Executive
Menashe Sonnenschein Executive
Dr. Elazar Sonnenschein Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
8 Omarim St.
Omer, L3, 8496500